BAYER CORPORATION (CONSOLIDATED REPORT)
EC
At a glance
Works on
Background
Career
BC
WASHINGTON, DC · current
Government experience
Health Policy Advisor
Sen. Al Franken
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Agriculture, Dept of (USDA)Environmental Protection Agency (EPA)Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)Natl Economic Council (NEC)SENATETreasury, Dept ofU.S. Trade Representative (USTR)White House Office
Specific issues
Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to FY2027 Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative and administrative action related to FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. H.R. 9171, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027. H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on legislative and administrative action related to Medicare inpatient reimbursement for cell and gene therapies. H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025.
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act.
Monitor and engage on legislative and federal activity related to tax reform. Monitor and engage on legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor and engage on legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor and engage on legislative and administrative issues related to foreign tax credit regulations. Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169), including the section 45Z tax credit and the sustainable aviation fuel tax credit. Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21).
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →